MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 145 filers reported holding MACROGENICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,646,272 | -30.7% | 353,277 | -20.4% | 0.00% | – |
| Q2 2023 | $2,374,089 | -48.5% | 443,755 | -31.0% | 0.00% | – |
| Q1 2023 | $4,613,566 | +6.2% | 643,454 | -0.6% | 0.00% | – |
| Q4 2022 | $4,342,859 | +61.1% | 647,222 | -17.0% | 0.00% | – |
| Q3 2022 | $2,696,000 | +35.0% | 779,348 | +15.0% | 0.00% | – |
| Q2 2022 | $1,997,000 | -63.0% | 677,449 | +10.5% | 0.00% | -100.0% |
| Q1 2022 | $5,401,000 | +36.8% | 613,114 | +149.3% | 0.00% | – |
| Q4 2021 | $3,948,000 | +433.5% | 245,965 | +595.9% | 0.00% | – |
| Q3 2021 | $740,000 | -86.7% | 35,344 | -82.9% | 0.00% | -100.0% |
| Q2 2021 | $5,562,000 | +750.5% | 207,082 | +908.2% | 0.00% | – |
| Q1 2021 | $654,000 | -49.1% | 20,539 | -63.5% | 0.00% | – |
| Q4 2020 | $1,286,000 | +37.7% | 56,300 | +51.8% | 0.00% | – |
| Q3 2020 | $934,000 | -4.5% | 37,089 | +5.9% | 0.00% | – |
| Q2 2020 | $978,000 | +539.2% | 35,012 | +33.8% | 0.00% | – |
| Q1 2020 | $153,000 | -83.5% | 26,163 | -69.3% | 0.00% | – |
| Q4 2019 | $928,000 | +30.5% | 85,242 | +53.0% | 0.00% | – |
| Q3 2019 | $711,000 | -17.2% | 55,705 | +10.1% | 0.00% | – |
| Q2 2019 | $859,000 | +1.2% | 50,602 | +7.1% | 0.00% | – |
| Q1 2019 | $849,000 | -0.2% | 47,244 | -29.5% | 0.00% | – |
| Q4 2018 | $851,000 | -65.5% | 66,993 | -41.7% | 0.00% | -100.0% |
| Q3 2018 | $2,464,000 | +10.4% | 114,926 | +6.3% | 0.00% | 0.0% |
| Q2 2018 | $2,231,000 | -49.2% | 108,084 | -38.0% | 0.00% | 0.0% |
| Q1 2018 | $4,389,000 | +209.7% | 174,423 | +133.9% | 0.00% | – |
| Q4 2017 | $1,417,000 | +3.3% | 74,587 | +0.5% | 0.00% | – |
| Q3 2017 | $1,372,000 | +25.6% | 74,189 | +19.0% | 0.00% | – |
| Q2 2017 | $1,092,000 | -48.7% | 62,367 | -45.5% | 0.00% | – |
| Q1 2017 | $2,128,000 | -45.0% | 114,446 | -39.6% | 0.00% | -100.0% |
| Q4 2016 | $3,872,000 | +908.3% | 189,394 | +1378.0% | 0.00% | – |
| Q3 2016 | $384,000 | +50.0% | 12,814 | +35.1% | 0.00% | – |
| Q2 2016 | $256,000 | -36.0% | 9,486 | -55.5% | 0.00% | – |
| Q1 2016 | $400,000 | +716.3% | 21,315 | +1251.6% | 0.00% | – |
| Q4 2015 | $49,000 | +104.2% | 1,577 | +38.6% | 0.00% | – |
| Q3 2015 | $24,000 | -91.8% | 1,138 | -85.2% | 0.00% | – |
| Q2 2015 | $292,000 | +228.1% | 7,699 | +171.5% | 0.00% | – |
| Q1 2015 | $89,000 | -97.8% | 2,836 | -97.6% | 0.00% | -100.0% |
| Q4 2014 | $4,087,000 | +1299.7% | 116,525 | +735.7% | 0.00% | – |
| Q3 2014 | $292,000 | -43.7% | 13,944 | -41.6% | 0.00% | – |
| Q2 2014 | $519,000 | +1165.9% | 23,893 | +1536.5% | 0.00% | – |
| Q1 2014 | $41,000 | -97.7% | 1,460 | -97.8% | 0.00% | -100.0% |
| Q4 2013 | $1,781,000 | – | 64,934 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,215,675 | $6,503,861 | 2.01% |
| Bellevue Group AG | 9,609,913 | $51,413,035 | 0.73% |
| Frazier Life Sciences Management, L.P. | 1,803,204 | $9,647,141 | 0.58% |
| ARMISTICE CAPITAL, LLC | 5,600,000 | $29,960,000 | 0.43% |
| Delphia (USA) Inc. | 37,988 | $203,236 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 352,497 | $1,885,859 | 0.31% |
| Corton Capital Inc. | 73,678 | $394,177 | 0.18% |
| Rock Springs Capital Management LP | 1,123,096 | $6,008,564 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 129,158 | $691 | 0.07% |
| PINNACLE ASSOCIATES LTD | 709,903 | $3,797,981 | 0.07% |